Patent details

EP3109258 Title: RECOMBINANT RSV ANTIGENS

Basic Information

Publication number:
EP3109258
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP161809264
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RECOMBINANT RSV ANTIGENS
French Title of Invention:
ANTIGÈNES RECOMBINANTS DU RSV
German Title of Invention:
REKOMBINANTE RSV-ANTIGENE
SPC Number:

Dates

Filing date:
23/12/2008
Grant date:
23/01/2019
EP Publication Date:
28/12/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/01/2019
EP B1 Publication Date:
23/01/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/12/2019
Expiration date:
23/12/2028
Renunciation date:
Revocation date:
12/10/2023
Annulment date:

Owner

From:
16/01/2019
 
 

Name:
GlaxoSmithKline Biologicals s.a.
Address:
rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Name:
ID Biomedical Corporation of Quebec
Address:
2323 Boul. du Parc Technologique Ste Foy, Quebec G1P 4R8, Canada (CA)

Inventor

1

Name:
RHEAULT, Patrick
Address:
Canada (CA)

2

Name:
RUELLE, Jean-Loius
Address:
Belgium (BE)

3

Name:
BAUDOUX, Jean-Pierre
Address:
Belgium (BE)

4

Name:
BLAIS, Normand
Address:
Canada (CA)

Priority

1

Priority Number:
16524 P
Priority Date:
24/12/2007
Priority Country:
United States (US)

2

Priority Number:
56206 P
Priority Date:
27/05/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/107; A61K 9/127; A61K 39/00; A61K 39/12; A61K 39/155; A61K 39/295; A61P 31/14; A61P 37/04; C07K 14/005; C07K 14/135; C07K 19/00; C12N 15/45; C12N 15/62;

Publication

European Patent Bulletin

1

Issue number:
201904
Publication date:
23/01/2019
Description:
Grant (B1)

2

Issue number:
201948
Publication date:
27/11/2019
Description:
Opposition procedure started

3

Issue number:
202401
Publication date:
03/01/2024
Description:
Revocation of the European patent

4

Issue number:
201909
Publication date:
27/02/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages